Blood Cancer News and Research

RSS
FDA approves new treatment for people with hairy cell leukemia

FDA approves new treatment for people with hairy cell leukemia

Novel treatment for hairy cell leukemia approved by FDA

Novel treatment for hairy cell leukemia approved by FDA

Drug combination targets pre-leukemia stem cells

Drug combination targets pre-leukemia stem cells

Researchers identify new cancerous cells responsible for acute myeloid leukemia relapse

Researchers identify new cancerous cells responsible for acute myeloid leukemia relapse

Researchers launch clinical trial to assess new drug combination against metastatic breast cancers

Researchers launch clinical trial to assess new drug combination against metastatic breast cancers

People with blood cancer less likely to understand their diagnosis

People with blood cancer less likely to understand their diagnosis

NUS scientists develop new technology to customize optimal drug ‘cocktail’ for myeloma patients

NUS scientists develop new technology to customize optimal drug ‘cocktail’ for myeloma patients

RNA and DNA sequencing platform matches broader swath of drugs to late-stage cancer patients

RNA and DNA sequencing platform matches broader swath of drugs to late-stage cancer patients

Research uncovers new approach for expanding stem cells from umbilical cord blood

Research uncovers new approach for expanding stem cells from umbilical cord blood

Rutgers researcher receives $100,000 grant to explore T-cell acute lymphoblastic leukemia

Rutgers researcher receives $100,000 grant to explore T-cell acute lymphoblastic leukemia

Janssen’s Darzalex receives positive CHMP opinion for treating multiple myeloma patients

Janssen’s Darzalex receives positive CHMP opinion for treating multiple myeloma patients

Survey: Blood cancers still take longer time for diagnosis than other types of cancer

Survey: Blood cancers still take longer time for diagnosis than other types of cancer

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

Researchers unravel how ALL invades the central nervous system

Researchers unravel how ALL invades the central nervous system

Researchers map family trees of cancer cells to understand how AML responds to new drug

Researchers map family trees of cancer cells to understand how AML responds to new drug

New study identifies inherited genetic variants that raise risk of clonal hematopoiesis

New study identifies inherited genetic variants that raise risk of clonal hematopoiesis

New findings refine link between clonal hematopoiesis and blood cancer risk

New findings refine link between clonal hematopoiesis and blood cancer risk

Researchers uncover molecular drivers of  a deadly pediatric cancer

Researchers uncover molecular drivers of a deadly pediatric cancer

Scientists discover new way to predict healthy individuals at risk of developing AML

Scientists discover new way to predict healthy individuals at risk of developing AML

CTI BioPharma announces Phase III results of PIXUVRI combined with rituximab in aggressive B-cell NHL patients

CTI BioPharma announces Phase III results of PIXUVRI combined with rituximab in aggressive B-cell NHL patients